Browse by author
Lookup NU author(s): Professor Andrew Trevelyan
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Inhibitory neuron behaviour is of fundamental importance to epileptic pathophysiology. When inhibition is compromised, such as by GABAergic blockade (Curtis et al., 1970; Connors, 1984; Traub and Miles, 1991) or by shifts in GABAergic reversal potential (Huberfeld et al., 2007), epileptiform discharges occur far more readily. Other studies have shown enhanced inhibition in vivo in the surrounding cortical territories associated with both focal pathological and physiological activity (Prince and Wilder, 1967; Dichter and Spencer, 1969a, b; Goldensohn and Salazar, 1986; Traub and Miles, 1991; Liang and Jones, 1997; Liang et al., 1998; Schwartz and Bonhoeffer, 2001). This gave rise to the concept of an “inhibitory restraint”. This concept can explain the often confusing anatomical reorganizations seen in chronically epileptic brains (Sloviter, 1987; Cossart et al., 2001), indicating which changes might be pro-epileptic, and which oppose the epileptic state. It also may explain key electrophysiological features of epileptic seizures. Here we describe current knowledge about the restraint, gleaned mainly from acute pharmacological experiments in animals, both in vivo and in vitro, and speculate how this may alter our understanding of human seizure activity in clinical practice.
Author(s): Trevelyan AJ, Schevon CA
Publication type: Review
Publication status: Published
Journal: Neuropharmacology
Year: 2013
Volume: 69
Pages: 45-54
Print publication date: 01/06/2013
Online publication date: 18/06/2012
Acceptance date: 08/06/2012
ISSN (print): 0028-3908
ISSN (electronic): 1873-7064
URL: http://dx.doi.org/10.1016/j.neuropharm.2012.06.015
DOI: 10.1016/j.neuropharm.2012.06.015
PubMed id: 22722026
